Abstract
Aim. As a part of outpatient registry PROFILE to study the thromboembolic risk (TER) according to CHA 2 DS 2 -VASc score, the structure and dynamics of antiplatelet drugs prescription for the patients with atrial fibrillation (AF) during two-year period (2012-2014). Material and methods. In the PROFILE registry the patients with AF were selected, requested medical assistance from 10.2013 till 06.2014 at specialized cardiological center. The visit was marked as Referent (RV). All patients (n=91) were retrospectively assessed using questionnaires, and medical data, and then they underwent the oral antithrombotic medication (OAM) evaluation that they had been receiving since 2012. Prospectively OAM therapy at the visit was evaluated by the data of medical documents filled: the main chart of a patient, included into PROFILE registry, and AF patient chart. The recommended therapy was analyzed. Results. During follow-up period there was relevant increase of OAM prescription to the patients with high TER and AF (p<0,05). In 2012 the OAM took 32,3% and in 2014 at RV — 63,8%. After RV to 84,6% patients the OAM were recommended. Increase of OAM prescription was found just by the novel OAM, warfarin prescription rate did not change: 25,6% in 2012 vs 24,2% at RV vs 20,9% of recommended during RV. Conclusion. Availability of novel OAM led to the increase of AF patients receiving OAM.
Highlights
oral antithrombotic medication (OAM) therapy at the visit was evaluated by the data of medical documents filled: the main chart of a patient, included into PROFILE registry, and atrial fibrillation (AF) patient chart
Availability of novel OAM led to the increase of AF patients receiving OAM
9. Go AS, Hylek EM, Chang Y, et al Anticoagulation therapy for stroke prevention in atrial терапии у пациентов с сердечно-сосудистыми заболеваниями
Summary
В рамках амбулаторного регистра ПРОФИЛЬ оценить риск тромбоэмболических осложнений (ТЭО) согласно шкале CHA2DS2VASc, структуру и динамику назначения антитромботических препа ратов пациентам с фибрилляцией предсердий (ФП) за двухлетний период (2012-2014гг). Проспективно оценена терапия ОАК на момент визита по данным заполненной медицинской докумен тации: общая карта пациента, включенного в регистр ПРОФИЛЬ, и карта пациента с ФП. За период наблюдения выявлено достоверное увеличение частоты назначения ОАК пациентам высокого риска с ТЭО и ФП (p
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
